Risk factors for endocrinological immune-related adverse events in patients with renal cell carcinoma treated with immune checkpoint inhibitors.

J Endocrinol Invest · 2026 · PMC12924852 · PMID 41212411

Europe PMC DOI

hedged sentence

0.3600

closest p · 7.2× alpha

0.3600

boldest claim

The sentences

did not reach statistical significancep = 0.36not close (p > 0.1)

Moreover, the association between TNM stage and both endocrine irAEs and thyroid dysfunction did not reach statistical significance in the log-rank analysis (p = 0.36 and p = 0.33, respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.